Revisiting Surrogate Endpoints in Clinical Trials of HF Devices

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Grant Support/Research Contract - Abbott; Applied Therapeutics; HeartFlow; AstraZenca; Novartis; Bristol-Myers Squibb</li><li>Board - Imbria; WhiteSwell</li><li>CMO - Jana Care</li></ul>